CalciMedica, Inc. — Form 8-K
Filed August 27, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
CalciMedica approved and executed a 5-for-1 reverse stock split effective August 27, 2026. Each five shares of common stock combine into one share; fractional shares are cashed out at the average closing price over the five trading days preceding filing. Authorized share count remains 100M common shares and 10M preferred shares.
Why this rating
Reverse split is routine corporate action; no assets, revenue, or valuation changed. Signals potential Nasdaq compliance concern but is standard administrative procedure.
See more from August 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.